Inventor · disambiguated record
Martina Ott
Also filed as: OTT MARTINA
17 granted patents·2 pending applications·47 citations·filing 2016–2025
93Inventor score
Top patents by PatentIndex Score
19 records- 0198US11116826B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 14, 2021·3 cites·20 claims
- 0298US10668138B1Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jun 2, 2020·4 cites·20 claims
- 0397US11007257B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted May 18, 2021·3 cites·20 claims
- 0497US11007258B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted May 18, 2021·3 cites·20 claims
- 0597US10898561B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Jan 26, 2021·3 cites·20 claims
- 0696US10792350B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Oct 6, 2020·3 cites·20 claims
- 0796US10729755B1Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Aug 4, 2020·3 cites·20 claims
- 0896US10576135B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Mar 3, 2020·5 cites·20 claims
- 0995US10561718B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Feb 18, 2020·4 cites·20 claims
- 1094US10449239B1Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 22, 2019·3 cites·20 claims
- 1190US10357551B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2018·Granted Jul 23, 2019·7 cites·21 claims
- 1288US10076560B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2016·Granted Sep 18, 2018·6 cites·13 claims
- 1387US12295995B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted May 13, 2025·0 cites·19 claims
- 1487US12295994B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted May 13, 2025·0 cites·19 claims
- 1587US12295996B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted May 13, 2025·0 cites·15 claims
- 1685US2025235519A1Novel peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2025·Application pending·0 cites
- 1781US12214025B2Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancersIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Feb 4, 2025·0 cites·17 claims
- 1859US11767352B2Histone anti-cancer vaccinesDEUTSCHES KREBSFORSCH·Filed 2020·Granted Sep 26, 2023·0 cites·5 claims
- 1935US2018155403A1Histone anti-cancer vaccinesUNIV HEIDELBERG RUPRECHT KARLS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martina Ott files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →